找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiation Therapy in Hematologic Malignancies; An Illustrated Pract Bouthaina Shbib Dabaja,Andrea K. Ng Book 2017 Springer International Pu

[復(fù)制鏈接]
樓主: Gullet
21#
發(fā)表于 2025-3-25 05:06:11 | 只看該作者
22#
發(fā)表于 2025-3-25 08:32:15 | 只看該作者
23#
發(fā)表于 2025-3-25 14:12:24 | 只看該作者
24#
發(fā)表于 2025-3-25 18:12:57 | 只看該作者
25#
發(fā)表于 2025-3-25 23:17:11 | 只看該作者
26#
發(fā)表于 2025-3-26 01:07:24 | 只看該作者
Radiation Therapy in the Management of Cutaneous T-Cell Lymphomas, Radiation therapy (RT) is an important palliative treatment modality in both advanced and localized cases. In this chapter, patients with advanced and early stage MF and pcALCL will be discussed. RT management in each of these cases will be addressed.
27#
發(fā)表于 2025-3-26 05:23:55 | 只看該作者
Extranodal Marginal Zone Lymphoma,tic strategies, with a special focus on the role of radiotherapy. Current recommendations in terms of optimal dose, volumes, and techniques are also presented. Few tables summarize the results of the largest series reporting on the outcome following radiotherapy, and figures illustrate imaging features as well as contouring and planning examples.
28#
發(fā)表于 2025-3-26 09:49:49 | 只看該作者
29#
發(fā)表于 2025-3-26 14:59:38 | 只看該作者
Extranodal Marginal Zone Lymphoma,ing virtually any organ, poses several challenges. The heterogeneity of the disease also explains the uncertainty and lack of consistency in radiotherapy approaches between centers and clinicians. EN-MZL often presents with localized/organ-confined disease, and RT is generally the primary curative m
30#
發(fā)表于 2025-3-26 17:36:48 | 只看該作者
Primary Mediastinal (Thymic) Large B-Cell Lymphoma,es that differ from diffuse large B-cell lymphoma (DLBCL). In the era of immunochemotherapy, a variety of chemotherapy regimens have been used for PMBL, including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP); rituximab, methotrexate, leucovorin, doxorubicin, cycloph
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 20:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
健康| 平原县| 南充市| 东丽区| 桐城市| 义乌市| 建水县| 翁牛特旗| 准格尔旗| 湘潭市| 东兰县| 合阳县| 宣武区| 平远县| 桂平市| 天等县| 长治市| 雷州市| 文水县| 韶山市| 苏尼特右旗| 昌吉市| 垫江县| 东辽县| 海门市| 城口县| 湟中县| 金堂县| 山丹县| 宝山区| 民勤县| 池州市| 新营市| 上饶市| 阿拉尔市| 芜湖市| 扎囊县| 平远县| 元谋县| 灯塔市| 阳朔县|